Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Assets Average (2022 - 2025)

Historic Assets Average for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to $470.2 million.

  • Centessa Pharmaceuticals' Assets Average fell 675.55% to $470.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $470.2 million, marking a year-over-year decrease of 675.55%. This contributed to the annual value of $468.5 million for FY2024, which is 1646.77% up from last year.
  • Latest data reveals that Centessa Pharmaceuticals reported Assets Average of $470.2 million as of Q3 2025, which was down 675.55% from $510.0 million recorded in Q2 2025.
  • Centessa Pharmaceuticals' 5-year Assets Average high stood at $593.3 million for Q4 2024, and its period low was $344.2 million during Q1 2024.
  • For the 4-year period, Centessa Pharmaceuticals' Assets Average averaged around $459.1 million, with its median value being $466.0 million (2022).
  • Its Assets Average has fluctuated over the past 5 years, first crashed by 2777.8% in 2023, then skyrocketed by 6085.91% in 2024.
  • Over the past 4 years, Centessa Pharmaceuticals' Assets Average (Quarter) stood at $461.8 million in 2022, then dropped by 20.14% to $368.8 million in 2023, then skyrocketed by 60.86% to $593.3 million in 2024, then dropped by 20.74% to $470.2 million in 2025.
  • Its Assets Average was $470.2 million in Q3 2025, compared to $510.0 million in Q2 2025 and $552.3 million in Q1 2025.